Skip to main content

Table 2 Clinical features of mild, moderate and severe groups of DKA on admission

From: Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period

Variables

Mild group

Moderate group

Severe group

Number of patients

25

21

19

Age (years)

59.0 ± 18.4

53.2 ± 14.9

46.3 ± 13.0 b

Gender (male: female)

11:14

14:7

13:6

History of DM (years)

7.62 ± 6.93

8.32 ± 5.93

4.77 ± 5.99

Hospital stay (days)

9.89 ± 5.86

11.14 ± 4.86

13.00 ± 4.40 b

Expenses (Yuan)

9958.0 ± 7267.5

11,085.9 ± 7952.6

12,336.4 ± 8080.6

RBG (mmol/L)

20.01 ± 5.32

20.45 ± 5.81

21.67 ± 7.20

HbA1c(%)

11.63 ± 2.66

11.47 ± 2.65

11.69 ± 2.52

Fasting C-peptide (ng/mL)

1.00 ± 0.89

0.39 ± 0.35 a

0.32 ± 0.31bb

Arterial PH

7.30 ± 0.02

7.21 ± 0.05 aa

7.11 ± 0.09 bb,cc

SB (mmol/L)

17.46 ± 2.23

12.37 ± 1.47 aa

7.20 ± 2.15 bb,cc

EPO (mOsm/L)

307.20 ± 14.21

310.66 ± 16.65

319.03 ± 11.72

Na (mmol/L)

135.84 ± 4.66

136.85 ± 6.08

135.05 ± 6.54

BUN (mmol/L)

7.65 ± 6.15

8.29 ± 4.86

8.09 ± 4.44

Cr (umol/L)

77.00 ± 25.05

102.52 ± 76.06

123.74 ± 83.72 b

CRP (mg/L)

10.50 (7.0–28.50)

67.19 ± 52.06

91.60 ± 64.79 bb

  1. Note: mild group vs moderate group, a P < 0.05, aa P < 0.01
  2. mild group vs severe group, b P < 0.05, bb P < 0.01
  3. moderate group vs severe group, cc P < 0.01